Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.77 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.77 |
| ▸ | MEN1 | O00255 | 2/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.77 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.77 |
| ▸ | FASN | P49327 | 5/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | CDC25A | P30304 | 1/20 | 0.33 |
| ▸ | CDC25B | P30305 | 1/20 | 0.33 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.33 |
| ▸ | DHODH | Q02127 | 1/20 | 0.33 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26468494 | 0.90 | ALOX5 (0.74) | ALOX5KDM4EMEN1KMT2AAKR1B10 | |
| SCHEMBL7897350 | 0.88 | MEN1 (0.74) | ALOX5KDM4EMEN1KMT2AAKR1B10 | |
| SCHEMBL144835 | 0.87 | ALOX5 (1.00) | ALOX5KDM4EMEN1KMT2AAKR1B10 | |
| SCHEMBL6125220 | 0.87 | ALOX5 (1.00) | ALOX5KDM4EMEN1KMT2AAKR1B10 | |
| SCHEMBL6125218 | 0.87 | ALOX5 (1.00) | ALOX5KDM4EMEN1KMT2AAKR1B10 | |
| SCHEMBL9773779 | 0.87 | ALOX5 (1.00) | ALOX5KDM4EMEN1KMT2AAKR1B10 | |
| SCHEMBL30428294 | 0.87 | ALOX5 (0.69) | ALOX5KDM4EMEN1KMT2AAKR1B10 | |
| Ammonia Solution, Strong SCHEMBL21582009 | 0.86 | ALOX5 (0.98) | ALOX5KDM4EMEN1KMT2AAKR1B10 | |
| SCHEMBL16269967 | 0.85 | ALOX5 (0.71) | ALOX5KDM4EMEN1KMT2AAKR1B10 | |
| SCHEMBL29405771 | 0.85 | ALOX5 (0.57) | ALOX5KDM4EMEN1KMT2AAKR1B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 247 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4623074-A1 | RECOMBINANT POLYPEPTIDES WITH PRENYLTRANSFERASE ACTIVITY FOR BIOSYNTHESIS OF CANNABINOIDS AND HOP COMPOUNDS | Epimeron USA, Inc. (US) | 2025-10-01 | — | — | EP | claimed |
| US-20250270598-A1 | RECOMBINANT POLYPEPTIDES WITH PRENYLTRANSFERASE ACTIVITY FOR BIOSYNTHESIS OF CANNABINOIDS AND HOP COMPOUNDS | EPIMERON USA, INC. (US) | 2025-08-28 | — | — | US | claimed |
| US-20250262262-A1 | a-ACID AND/OR B-ACID BASED COPOSITIONS FROM HUMULUS FOR USE IN A HUMAN AND/OR VETERINARY APPLICATION | OROTECH NV (BE) | 2025-08-21 | — | — | US | claimed |
| WO-2025046278-A1 | ANTIMICROBIAL COMPOSITIONS AND METHODS THEREOF | DANSTAR FERMENT AG (CH) | 2025-03-06 | — | — | WO | claimed |
| EP-4514317-A1 | ?-ACID AND/OR SS-ACID BASED COMPOSITIONS FROM HUMULUS FOR USE IN A HUMAN AND/OR VETERINARY APPLICATION | Orotech NV (BE) | 2025-03-05 | — | — | EP | claimed |
| EP-4263781-B1 | PROCESS FOR PREPARING A HOP EXTRACT AND A LOW ALCOHOLIC BEER COMPRISING THE SAME | HEINEKEN SUPPLY CHAIN BV (NL) | 2025-02-12 | — | — | EP | claimed |
| WO-2024112694-A1 | RECOMBINANT POLYPEPTIDES WITH PRENYLTRANSFERASE ACTIVITY FOR BIOSYNTHESIS OF CANNABINOIDS AND HOP COMPOUNDS | WILLOW BIOSCIENCES, INC. (CA) | 2024-05-30 | — | — | WO | claimed |
| US-11884870-B2 | Use of a process fluid with an environmentally compatible biostabilizer in a geothermal borehole | AGRANA BETEILIGUNGS-AKTIENGESELLSCHAFT (AT) | 2024-01-30 | — | — | US | claimed |
| US-11827847-B2 | Process fluid with environmentally friendly biostabilisator | AGRANA BETEILIGUNGS-AKTIENGESELLSCHAFT (AT) | 2023-11-28 | — | — | US | claimed |
| WO-2023209173-A1 | α-ACID AND/OR ß-ACID BASED COMPOSITIONS FROM HUMULUS FOR USE IN A HUMAN AND/OR VETERINARY APPLICATION | OROTECH NV (BE) | 2023-11-02 | — | — | WO | claimed |
| EP-4263781-A1 | HOP EXTRACT | Heineken Supply Chain B.V. (NL) | 2023-10-25 | — | — | EP | claimed |
| US-20230332077-A1 | HOP EXTRACT | HEINEKEN SUPPLY CHAIN B.V. (NL) | 2023-10-19 | — | — | US | claimed |
| CN-116568796-A | Hops extract | 喜力供应链有限公司 | 2023-08-08 | — | — | CN | claimed |
| US-20230083037-A1 | PROCESS FLUID WITH ENVIRONMENTALLY FRIENDLY BIOSTABILISATOR | AGRANA BETEILIGUNGS-AKTIENGESELLSCHAFT (AT) | 2023-03-16 | — | — | US | claimed |
| WO-2022240895-A1 | METHODS TO SYNTHESIZE CYCLOPENTENES AND CYCLOPENTADIENES BY RING CONTRACTION | Natural Extraction Systems, LLC (US) | 2022-11-17 | — | — | WO | claimed |
| WO-2022129082-A1 | HOP EXTRACT | HEINEKEN SUPPLY CHAIN B.V. (NL) | 2022-06-23 | — | — | WO | claimed |
| US-12636251-B1 | Glycoside-containing aqueous formulations having a lipophilic active component | Doane Technology Group LLC (US) | 2026-05-26 | — | — | US | disclosed |
| EP-4734922-A2 | ORAL CARE COMPOSITIONS COMPRISING HOPS BETA ACIDS AND TIN | The Procter & Gamble Company (US) | 2026-05-06 | — | — | EP | disclosed |
| EP-3958982-A1 | SYSTEMS AND METHODS FOR DELIVERING ACTIVE AGENTS | The Procter & Gamble Company (US) | 2022-03-02 | — | — | EP | disclosed |
| CN-108603150-B | Photostable hops extract | 喜力供应链有限公司 | 2022-02-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12636251-B1 | Glycoside-containing aqueous formulations having a lipophilic active component | CNR2, CNR1, LIPC | ALOX5 754/4885KDM4E 3730/4885MEN1 1775/4885 |
| US-20250262262-A1 | a-ACID AND/OR B-ACID BASED COPOSITIONS FROM HUMULUS FOR USE IN A HUMAN AND/OR VETERINARY APPLICATION | CYP8B1, HMBS, HPD | ALOX5 339/4885KDM4E 1425/4885MEN1 3777/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.